Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Observational Study to Assess The Efficacy, Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist

NCT00445107 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00445107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00445107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Observational Study to Assess The Efficacy, Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
November 1, 2005
Completion date
May 17, 2006
Enrollment
198 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma